{"id":531902,"date":"2021-02-25T18:36:01","date_gmt":"2021-02-25T18:36:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=531902"},"modified":"2021-02-25T18:36:01","modified_gmt":"2021-02-25T18:36:01","slug":"covid19-coronavirus-pipeline-landscape-report-2020-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/covid19-coronavirus-pipeline-landscape-report-2020-by-delveinsight_531902.html","title":{"rendered":"COVID-19 (CoronaVirus) Pipeline Landscape Report 2020 by DelveInsight"},"content":{"rendered":"
\"COVID-19<\/a><\/p>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
\u201cCOVID-19 (CoronaVirus) Pipeline Insight, 2020\u201d report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across COVID-19 (CoronaVirus). A detailed picture of the pipeline landscape is provided with a summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration, and molecule type.<\/div>\n

“COVID-19 (CoronaVirus) Pipeline Insight, 2020<\/strong><\/a>” report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across COVID-19 (CoronaVirus). A detailed picture of the pipeline landscape is provided with a summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration, and molecule type.<\/p>\n

\"\"<\/p>\n

Scope of the report:<\/strong><\/p>\n

• Provides an overview of therapeutic pipeline activity for COVID-19(CoronaVirus) across the complete product development cycle including all clinical and non-clinical stages<\/p>\n

• It comprises detailed profiles of COVID-19 (CoronaVirus) therapeutic products<\/strong><\/a> with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies, and chemical information<\/p>\n

• Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration<\/p>\n

• Coverage of dormant and discontinued pipeline projects across COVID-19(CoronaVirus)<\/p>\n

Request for a free sample copy of the report: https:\/\/www.delveinsight.com\/sample-request\/covid-19-coronavirus-pipeline-insights<\/span><\/a><\/strong><\/p>\n

Key pharma players involved:<\/strong><\/p>\n

1. Janssen Pharmaceutical <\/p>\n

2. AstraZeneca<\/p>\n

3. Azidus Brasil<\/p>\n

4. NeuTec Pharma <\/p>\n

5. Dr. Reddy’s laboratories<\/p>\n

6. Symvivo Corporation<\/p>\n

7. Janssen Pharmaceutical <\/p>\n

Click here and download a free sample copy of the report.<\/strong><\/a><\/p>\n

Table of contents:<\/strong><\/p>\n

1. Report Introduction<\/p>\n

2. COVID-19(CoronaVirus) – Disease Overview<\/p>\n

3. Pipeline Outlook<\/p>\n

4. Comparative Analysis<\/p>\n

5. COVID-19(CoronaVirus) Therapeutic Products in Clinical Stage<\/p>\n

6. COVID-19(CoronaVirus) Therapeutic Products in Non-clinical Stage<\/p>\n

7. Therapeutic Pipeline Analysis<\/p>\n

8. Inactive Pipeline Products<\/p>\n

9. Appendix<\/p>\n

10. Report Methodology<\/p>\n

11. Consulting Services<\/p>\n

12. Disclaimer<\/p>\n

13. About DelveInsight<\/p>\n

Download our report: https:\/\/www.delveinsight.com\/report-store\/covid-19-coronavirus-pipeline-insights<\/span><\/a><\/strong><\/p>\n

About DelveInsight<\/strong>
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/span><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight Business Research LLP<\/a>
Contact Person:<\/strong> Kritika Rehani
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 9193216187
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Las Vegas
State:<\/strong> Nevada
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

DelveInsight Business Research LLP \u201cCOVID-19 (CoronaVirus) Pipeline Insight, 2020\u201d report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across COVID-19 (CoronaVirus). A detailed picture of the pipeline landscape is provided with a summation of data from multiple … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-531902","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/531902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=531902"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/531902\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=531902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=531902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=531902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}